Clifford Swan Investment Counsel’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$347K Sell
1,571
-49
-3% -$13.6K 0.01% 265
2026
Q1
$478K Hold
1,620
0.02% 217
2025
Q4
$442K Hold
1,620
0.01% 233
2025
Q3
$438K Buy
1,620
+34
+2% +$9.25K 0.01% 233
2025
Q2
$437K Buy
1,586
+2
+0.1% +$544 0.02% 232
2025
Q1
$420K Hold
1,584
0.02% 229
2024
Q4
$368K Sell
1,584
-67
-4% -$15.4K 0.01% 245
2024
Q3
$364K Buy
1,651
+13
+0.8% +$2.69K 0.01% 254
2024
Q2
$322K Sell
1,638
-17
-1% -$3.51K 0.01% 257
2024
Q1
$356K Hold
1,655
0.01% 249
2023
Q4
$349K Sell
1,655
-120
-7% -$25.6K 0.01% 247
2023
Q3
$355K Hold
1,775
0.01% 243
2023
Q2
$329K Hold
1,775
0.01% 249
2023
Q1
$340K Sell
1,775
-100
-5% -$18.1K 0.01% 244
2022
Q4
$315K Hold
1,875
0.01% 250
2022
Q3
$332K Sell
1,875
-97
-5% -$19.2K 0.02% 246
2022
Q2
$404K Sell
1,972
-6
-0.3% -$1.27K 0.02% 241
2022
Q1
$470K Sell
1,978
-34
-2% -$7.99K 0.02% 238
2021
Q4
$460K Sell
2,012
-51
-2% -$11.2K 0.02% 246
2021
Q3
$450K Hold
2,063
0.02% 244
2021
Q2
$430K Hold
2,063
0.02% 239
2021
Q1
$421K Hold
2,063
0.02% 237
2020
Q4
$376K Hold
2,063
0.02% 248
2020
Q3
$345K Sell
2,063
-197
-9% -$33.2K 0.02% 244
2020
Q2
$367K Sell
2,260
-350
-13% -$62.7K 0.02% 234
2020
Q1
$451K Sell
2,610
-221
-8% -$44K 0.03% 205
2019
Q4
$568K Hold
2,831
0.03% 203
2019
Q3
$598K Hold
2,831
0.03% 191
2019
Q2
$550K Sell
2,831
-30
-1% -$5.53K 0.03% 199
2019
Q1
$471K Sell
2,861
-300
-9% -$53K 0.03% 214
2018
Q4
$595K Sell
3,161
-36
-1% -$6.65K 0.04% 187
2018
Q3
$544K Hold
3,197
0.03% 202
2018
Q2
$524K Hold
3,197
0.03% 202
2018
Q1
$517K Sell
3,197
-278
-8% -$44.3K 0.03% 202
2017
Q4
$508K Hold
3,475
0.03% 207
2017
Q3
$471K Sell
3,475
-235
-6% -$29.7K 0.03% 212
2017
Q2
$465K Hold
3,710
0.03% 220
2017
Q1
$441K Hold
3,710
0.03% 211
2016
Q4
$428K Hold
3,710
0.03% 209
2016
Q3
$388K Buy
+3,710
New +$387K 0.03% 213

Other funds holding CME

Clifford Swan Investment Counsel's CME Position: Q2 2026 in Review

Clifford Swan Investment Counsel reduced its CME Group (CME) stake by 3% in Q2 2026, selling an estimated $13.6K and leaving 1,571 shares worth $347K. The position accounts for 0.01% of the portfolio, ranked #265.

Clifford Swan Investment Counsel first reported a position in CME in Q3 2016 and has held it in 40 quarters since. The position peaked at $598K in Q3 2019. 1,698 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • Clifford Swan Investment Counsel held 1,571 shares of CME Group worth $347K as of Q2 2026.
  • Clifford Swan Investment Counsel sold 49 CME Group shares in Q2 2026, an estimated $13.6K.
  • CME Group made up 0.01% of Clifford Swan Investment Counsel's portfolio in Q2 2026, its #265 holding.
  • Clifford Swan Investment Counsel first reported a position in CME Group in Q3 2016 and has held it in 40 quarters since.
  • Clifford Swan Investment Counsel's CME Group position peaked at $598K in Q3 2019.
  • 1,698 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Clifford Swan Investment Counsel's 13F filing for Q2 2026, filed 20 Aug 2026.